Zobrazeno 1 - 10
of 159
pro vyhledávání: '"Jan, Stasko"'
Autor:
Miroslava Drotarova, Jana Zolkova, Kristina Maria Belakova, Monika Brunclikova, Ingrid Skornova, Jan Stasko, Tomas Simurda
Publikováno v:
Diagnostics, Vol 13, Iss 20, p 3219 (2023)
Rotational thromboelastometry (ROTEM) is a viscoelastic method, which provides a graphical and numerical representation of induced hemostasis in whole blood samples. Its ability to quickly assess the state of hemostasis is used in the management of b
Externí odkaz:
https://doaj.org/article/b59dfeee6170445ba1ab50d5dda803f4
Autor:
Ingrid Skornova, Tomas Simurda, Lucia Stanciakova, Viliam Lauko, Pavol Holly, Matej Samos, Tomas Bolek, Martin Schnierer, Miroslava Drotarova, Kristina Maria Belakova, Juraj Sokol, Jan Stasko, Marian Mokan, Jaroslav Gumulec, Leona Chrastinova
Publikováno v:
Diagnostics, Vol 13, Iss 18, p 3019 (2023)
Heparin-induced thrombocytopenia (HIT) is a life-threatening complication of heparin therapy (both unfractionated heparin and low-molecular-weight heparin). In our study, we examined a group of 122 patients with suspected HIT. The samples of all pati
Externí odkaz:
https://doaj.org/article/e998bf12e7e04cfa945152c1b65dbb09
Autor:
Monika Brunclikova, Jela Ivankova, Maria Skerenova, Tomas Simurda, Lucia Stanciakova, Ingrid Skornova, Miroslava Sterankova, Jana Zolkova, Miroslava Dobrotova, Pavol Holly, Peter Kubisz, Jan Stasko
Publikováno v:
Acta Medica Martiniana, Vol 22, Iss 1, Pp 34-44 (2022)
Introduction: Inherited platelet hyperaggregability, so called “Sticky platelet syndrome” (SPS), is a prothrombotic platelet disorder. The syndrome contributes more often to arterial than venous thrombosis. The most common localization of arteria
Externí odkaz:
https://doaj.org/article/81cad9474a4041239c0c6896498e153f
Autor:
Lucia Stanciakova MD, PhD, Miroslava Dobrotova MD, PhD, Pavol Holly MD, PhD, Jana Zolkova MSc, PhD, Lubica Vadelova MSc, PhD, Ingrid Skornova MA, PhD, Jela Ivankova MSc, Matej Samos MD, PhD, Tomas Bolek MD, PhD, Marian Grendar MSc, PhD, Jan Danko MD, PhD, Peter Kubisz MD, DSc, Jan Stasko MD, PhD
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 28 (2022)
Low-molecular-weight heparin (LMWH) is suggested for thromboprophylaxis in pregnant women with previous venous thromboembolism (VTE ) . Anyway, there is only limited amount of studies evaluating the effect of LMWH on hemostatic parameters during preg
Externí odkaz:
https://doaj.org/article/1446eff435f34e45a8e508419e73fd28
Autor:
Petr Vrtel, Ludek Slavik, Radek Vodicka, Julia Stellmachova, Martin Prochazka, Jana Prochazkova, Jana Ulehlova, Peter Rohon, Tomas Simurda, Jan Stasko, Ivana Martinkova, Radek Vrtel
Publikováno v:
Diagnostics, Vol 12, Iss 5, p 1060 (2022)
The deficiency of natural anticoagulants—antithrombin (AT), protein C (PC), and protein S (PS)—is a highly predisposing factor for thrombosis, which is still underdiagnosed at the genetic level. We aimed to establish and evaluate an optimal diagn
Externí odkaz:
https://doaj.org/article/003c59edd04342368e96e880a89cfc57
Autor:
Juraj Sokol MD, PhD, Frantisek Nehaj MD, Jela Ivankova RNDr, Michal Mokan MD, PhD, Jana Zolkova RNDr, Lenka Lisa MD, PhD, Ludmila Linekova MD, Marian Mokan MD, DSc, FRCP Edin, Jan Stasko MD, PhD
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 27 (2021)
A rapid and reliable assessment of the dabigatran effect is desirable in dabigatran treated patients with uncontrolled bleeding or before acute surgery. The aim of this study was to study the anticoagulant effects of dabigatran in patients with atria
Externí odkaz:
https://doaj.org/article/45ffc6ca78f2438e8496473c24f36106
Autor:
Juraj Sokol MD, PhD, Frantisek Nehaj MD, Jela Ivankova RNDr, Michal Mokan MD, PhD, Lenka Lisa MD, PhD, Jana Zolkova RNDr, Lubica Vadelova RNDr, Marian Mokan Prof, MD, DSc, FRCP Edin, Jan Stasko Prof, MD, PhD
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 26 (2020)
Edoxaban, a direct factor Xa inhibitor (FXa), is the fourth direct oral anticoagulant (DOAC) approved for clinical use. As the main adverse event is bleeding, it is relevant whether edoxaban has additional effects on platelet function. We aimed to as
Externí odkaz:
https://doaj.org/article/90ee2f85093240908bd3f4c5594d9b6e
Autor:
Monika Brunclikova, Tomas Simurda, Jana Zolkova, Miroslava Sterankova, Ingrid Skornova, Miroslava Dobrotova, Zuzana Kolkova, Dusan Loderer, Marian Grendar, Jan Hudecek, Jan Stasko, Peter Kubisz
Publikováno v:
Journal of Clinical Medicine, Vol 11, Iss 4, p 1083 (2022)
Congenital fibrinogen disorders are diseases associated with a bleeding tendency; however, there are also reports of thrombotic events. Fibrinogen plays a role in the pathogenesis of thrombosis due to altered plasma concentrations or modifications to
Externí odkaz:
https://doaj.org/article/bed0d4d8ea834cc18101bf03adc25b19
Autor:
Andrea Vazanova, Jana Jurecekova, Tomas Balharek, Juraj Marcinek, Jan Stasko, Anton Dzian, Lukas Plank, Pavol Zubor, Peter Racay, Jozef Hatok
Publikováno v:
Cancer Cell International, Vol 18, Iss 1, Pp 1-10 (2018)
Abstract Background Apoptosis plays an important role in the development and homeostasis of multicellular organisms and its deregulation may result in many serious diseases, including cancer. Now it is clear that some oncogenic mutations disrupt apop
Externí odkaz:
https://doaj.org/article/ac8c2fb4860643a3a742247cc9a0a196
Autor:
Tomas Simurda, Rosanna Asselta, Jana Zolkova, Monika Brunclikova, Miroslava Dobrotova, Zuzana Kolkova, Dusan Loderer, Ingrid Skornova, Jan Hudecek, Zora Lasabova, Jan Stasko, Peter Kubisz
Publikováno v:
Diagnostics, Vol 11, Iss 11, p 2140 (2021)
Congenital fibrinogen disorders are rare pathologies of the hemostasis, comprising quantitative (afibrinogenemia, hypofibrinogenemia) and qualitative (dysfibrinogenemia and hypodysfibrinogenemia) disorders. The clinical phenotype is highly heterogene
Externí odkaz:
https://doaj.org/article/1b2962a9071f4dddb96c55543b50554b